Jimmy Chang

Special Assistant to Chairman, Wistron Medical Technology

Speaker Info

Medical AI, a Wistron Perspective

Abstract: AI has played major roles in facilitating and improving the flow and outcomes of healthcare management.  In particular, the demands in disease screening, diagnostics, Drug Development, Personalized Care, and Gene Editing have been greatly benefited with AI in play.  With the challenges and opportunities arising of the Aging Society, Wistron chooses to focus on selected Cloud and Edge AI solutions to address the needs in Elderly Care as well as Personalized Mobility technologies and products.  This not only showcases Wistron’s commitment in ESG responsibility for the society but also opens huge business potential for future growth.

Speaker Info


Education and awards
  • MS Biomedical Engineering
    U. of Miami, FL, USA 1988
  • Operation Excellence Award
    TomTec Imaging 1996
  • Competitive Strategy Leadership Award Frost & Sullivan 2008
  • Product Innovation Award
    Frost & Sullivan 2017
  • 20+ International Patents Medical Imaging & Image Guided Therapies
  • TomTec Imaging (USA) 1991-97
    Senior Vice President
    3D Ultrasound Innovation & Business Development
  • Samsung Medical (Medison) 1997-99
    CEO, Greater China
    Medical Ultrasound Business Management
  • New Medical (Taiwan) 2001-08
    Founder & CEO
    Digital Radiography Innovation & Business Development
  • INFINITT (Greater China) 2002-08
    Founder & Chairman
    PACS Business Development
  • CHISON (China) 2008-09
    Strategic Consultant
    Ultrasound Business Development
  • Vieworks (Korea) 2009-10
    Strategic Consultant
    Digital Radiography Strategic Development
  • EpiSonica (Cayman) 2013-18
    Founder & CEO
    MRI-guided HIFU Therapy & ABUS 3D Breast Imaging
  • Taiwania Capital 2018-20
    Entrepreneur in Residence
    Medical Device Investment & Portfolio Consultation
  • Wistron Medical Technology 2020-Present
    Special Assistance to Chairman Strategic Development